The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mahatme Sandesh since 2013.
The trader's CIK number is 1511034.
At the time of the last reporting, Mahatme Sandesh was the Senior Vice President, CFO of Sarepta Therapeutics, Inc.. (stock ticker symbol SRPT).
Also see all insider trading activities at Sarepta Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | SRPT | 0 | $0 | 0 | $0 | 3,806 | $76,184 |
| 2019 | SRPT | 0 | $0 | 255,000 | $33,577,762 | 380,240 | $8,692,410 |
| 2018 | SRPT | 0 | $0 | 107,524 | $13,735,115 | 98,549 | $1,516,219 |
| 2017 | SRPT | 0 | $0 | 50,000 | $2,050,000 | 64,798 | $893,424 |
| 2016 | SRPT | 0 | $0 | 30,000 | $1,502,490 | 31,000 | $440,850 |
| 2013 | SRPT | 5,000 | $155,500 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-07-08 | SRPT | Option Ex | 3,806 | 20.02 | 76,184 |
| 2019-12-13 | SRPT | Option Ex | 125,000 | 24.64 | 3,080,250 |
| 2019-12-13 | SRPT | Sale | 125,000 | 125.50 | 15,687,500 |
| 2019-08-21 | SRPT | Option Ex | 100,000 | 23.85 | 2,385,000 |
| 2019-08-15 | SRPT | Option Ex | 9,754 | 21.05 | 205,360 |
| 2019-03-19 | SRPT | Option Ex | 15,486 | 16.29 | 252,313 |
| 2019-02-07 | SRPT | Sale | 65,000 | 145.00 | 9,425,000 |
| 2019-02-07 | SRPT | Option Ex | 65,000 | 23.85 | 1,550,250 |
| 2019-01-31 | SRPT | Sale | 21,198 | 130.72 | 2,771,002 |
| 2019-01-30 | SRPT | Option Ex | 43,802 | 16.29 | 713,665 |
| 2019-01-31 | SRPT | Option Ex | 21,198 | 23.85 | 505,572 |
| 2019-01-30 | SRPT | Sale | 43,802 | 130.00 | 5,694,260 |
| 2018-10-24 | SRPT | Option Ex | 89,400 | 16.29 | 1,456,594 |
| 2018-10-24 | SRPT | Sale | 107,524 | 127.74 | 13,735,115 |
| 2018-05-22 | SRPT | Option Ex | 6,649 | .00 | 0 |
| 2018-03-15 | SRPT | Option Ex | 2,500 | 23.85 | 59,625 |
| 2017-08-03 | SRPT | Option Ex | 13,298 | .00 | 0 |
| 2017-07-20 | SRPT | Sale | 50,000 | 41.00 | 2,050,000 |
| 2017-07-21 | SRPT | Option Ex | 1,500 | 23.85 | 35,775 |
| 2017-07-20 | SRPT | Option Ex | 50,000 | 17.15 | 857,649 |
| 2016-11-09 | SRPT | Option Ex | 1,000 | 23.85 | 23,850 |
| 2016-10-17 | SRPT | Option Ex | 30,000 | 13.90 | 417,000 |
| 2016-10-17 | SRPT | Sale | 30,000 | 50.08 | 1,502,490 |
| 2013-08-20 | SRPT | Buy | 5,000 | 31.10 | 155,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mahatme Sandesh (Senior Vice President, CFO of Sarepta Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.